Stock Markets Review For 1995

15 January 1996

The UK's FT-SE 100 index started 1995 at 3,066 and finished the year at 3,689.3, up 20.3%, more or less in line with the expectations of UK market observers, and considered to be a good performance. Interest rates came down quicker than some expected during the year and the bond markets were stronger than anticipated. In the USA, the Dow Jones Industrial was up 33.5% to 5,117.12 by year-end from 3,833 in January, and in Japan, the Nikkei stood at 19,723 at the start of the year, finishing at 19,868.15, a rise of just 0.7%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight